Parkleton Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 14-06-2024
- Paid Up Capital ₹ 0.10 M
as on 14-06-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 16.80 Cr
as on 14-06-2024
- Revenue -16.99%
(FY 2023)
- Profit -2.22%
(FY 2023)
- Ebitda 19.18%
(FY 2023)
- Net Worth 41.07%
(FY 2023)
- Total Assets -30.87%
(FY 2023)
About Parkleton
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹16.80 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Monika Jain and Parth Jain serve as directors at the Company.
- CIN/LLPIN
U74999DL2013PTC260458
- Company No.
260458
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Parkleton Private Limited offer?
Parkleton Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Common Disease Medicines, Cough Syrup, Anti Infective Drugs & Medicines, Antiviral Drugs.
Who are the key members and board of directors at Parkleton?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monika Jain  | Director | 25-Jan-2017 | Current |
| Parth Jain | Director | 24-Aug-2016 | Current |
Financial Performance of Parkleton.
Parkleton Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 16.99% decrease. The company also saw a slight decrease in profitability, with a 2.22% decrease in profit. The company's net worth Soared by an impressive increase of 41.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parkleton?
In 2023, Parkleton had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Nov 2019 | ₹16.80 Cr | Satisfied |
How Many Employees Work at Parkleton?
Unlock and access historical data on people associated with Parkleton, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parkleton, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parkleton's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
